31 research outputs found
Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care : a real-world study
Acknowledgements Samantha Holmes (CircleScience, an Ashfield Company, part of UDG Healthcare plc) and Paul Hutchin (contracted to CircleScience, an Ashfield Company, part of UDG Healthcare plc) provided medical writing assistance. Funding The study was funded by Novartis Pharma AG (Basel, Switzerland).Peer reviewedPublisher PD
Management of COPD in the UK primary-care setting : an analysis of real-life prescribing patterns
Peer reviewedPublisher PD
The inevitable drift to triple therapy in COPD : an analysis of prescribing pathways in the UK
Acknowledgments The analyses reported in this study were funded by Novartis Pharma AG (Basel, Switzerland) and were conducted by Research in Real-Life Ltd (Cambridge, UK), an independent company. The authors also thank David Bergin, Danielle Corbett, and Vivek Khanna (professional medical writers; Novartis) for assistance in the preparation of this paper. Writing support was funded by Novartis Pharma AG.Peer reviewedPublisher PD
Erratum : Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world study
Peer reviewedPublisher PD
Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting
Acknowledgements The iHARP database was funded by unrestricted grants from Mundipharma International Ltd and Research in Real-Life Ltd; these analyses were funded by an unrestricted grant from Teva Pharmaceuticals. Mundipharma and Teva played no role in study conduct or analysis and did not modify or approve the manuscript. The authors wish to direct a special appreciation to all the participants of the iHARP group who contributed data to this study and to Mundipharma, sponsors of the iHARP group. In addition, we thank Julie von Ziegenweidt for assistance with data extraction and Anna Gilchrist and Valerie L. Ashton, PhD, for editorial assistance. Elizabeth V. Hillyer, DVM, provided editorial and writing support, funded by Research in Real-Life, Ltd.Peer reviewedPublisher PD
The Burden of Self-Reported Rhinitis and Associated Risk for Exacerbations with Moderate-Severe Asthma in Primary Care Patients
Acknowledgments: The iHARP database was funded by unrestricted grants from Mundipharma International Limited and Optimum Patient Care Global Ltd, which is a social enterprise that focuses on quality improvement in clinical practice. The sponsor was not involved in data analysis or the interpretation of the results.Peer reviewedPublisher PD
Novel study design to assess the utility of the copd assessment test in a primary care setting
The quality of a consultation provided by a physician can have a profound impact on the quality of care and
patient engagement in treatment decisions. When the COPD Assessment Test (CAT) was developed, one of its aims
was to aid the communication between physician and patient about the impact of COPD. We developed a novel
study design to assess this in a primary care consultation.
Primary care physicians across five countries in Europe conducted videoed consultations with six standardised
COPD patients (played by trained actors) which had patient-specific issues that the physician needed to identify
through questioning. Half the physicians saw the patients with the completed CAT, and half without. Independent
assessors scored the physicians on their ability to identify and address the patient-specific issues, review standard COPD aspects, their understanding of the case and their overall performance. This novel study design presented
many challenges which needed to be addressed to achieve an acceptable level of robustness to assess the utility of
the CAT. This paper discusses these challenges and the measures adopted to eliminate or minimise their impact on
the study results
A multinational observational study identifying primary care patients at risk of overestimation of asthma control
The International Primary Care Respiratory Group (IPCRG) has facilitated the publication of this paper. The iHARP database was funded by unrestricted grants from Mundipharma International Limited and Optimum Patient Care Global Ltd, which is a social enterprise that focuses on quality improvement in clinical practice. The sponsor was not involved in data analysis or the interpretation of the results.Peer reviewedPublisher PD
Can asthma control be improved by understanding the patient's perspective?
Clinical trials show that asthma can be controlled in the majority of patients, but poorly controlled asthma still imposes a considerable burden. The level of asthma control achieved reflects the behaviour of both healthcare professionals and patients. A key challenge for healthcare professionals is to help patients to engage in self-management behaviours with optimal adherence to appropriate treatment. These issues are particularly relevant in primary care, where most asthma is managed. An international panel of experts invited by the International Primary Care Respiratory Group considered the evidence and discussed the implications for primary care practice